To include your compound in the COVID-19 Resource Center, submit it here.

Sienna rises after pricing $65M IPO

Dermatology company Sienna Biopharmaceuticals Inc. (NASDAQ:SNNA) gained $4.25 (28%) to $19.25 on

Read the full 122 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE